Nevro stock: buy or sell?
February 27th, 2020
Nevro Corp., a medical device company, provides products for the patients suffering from chronic pain in the United States and internationally.
Should I buy Nevro stock?Trading stocks requires experience and discipline, and your buying and selling decisions must come following a methodology. Having a trading plan helps to make decisions easier, quicker and with less hesitations. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
Currently, Nevro stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Nevro stock a buy?
Financial institutions and banks publish stock ratings everyday.Unfortunately, we couldn't find any rating for NVRO stock for the last month.
Nevro stock analysis
Nevro eased -2.45% to $135.59 after reaching all time highs yesterday.
After reaching all time highs yesterday, Nevro eased -2.45% today to $135.59. Yesterday, NVRO hit new all time highs, pushing higher previous ATH of $145.56 recorded on February/19. New ATHs are usual entry points for many trading setups as there aren't higher resistences. Since last November when NVRO stock price broke up the SMA50d line, it gained $50.34 (59.05%).
Nevro closed this week at $135.59 after marking a new all time high ($148.05) even it couldn't close with gains and slightly fell a tragic -1.92%. Late January NVRO boosted an amazing 6.06% in just one week.
NVRO shows a strong mid-term uptrend with several rising tops and rising bottoms. Since its last bottom by mid January, NVRO climbed unceasignly breaking out to new all time highs. Since SMA20d and SMA40w crossed up by mid May 2019, NVRO price climbed $75.39 per share (125.23%). Since mid March 2019 when NVRO stock price broke up the SMA40w line, it gained $91.90 (210.35%).
Nevro stock price history
Nevro IPO was on November 6th, 2014 at $23.40 per share1. Since then, NVRO stock surged a 479.40%, with an average of 95.90% per year. If you had invested $1,000 in Nevro stock in 2014, it would worth $4,794.00 today.
1: Adjusted price after possible price splits or reverse-splits.
Nevro stock historical price chart
NVRO stock reached all-time highs yesterday with a price of $148.05.
Nevro stock price targetNobody can reliably foresee how stock prices may evolve in the future. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. You should not follow the analysts' NVRO stock price predictions in the hope that they will be met as they may be wrong and not met. For the last month we have not found any price prediction for Nevro stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per Share, Nevro presented its financial report, posting an exceptional growth for the Earnings per Share (EPS). Experts were expecting $-0.17 per share, but Nevro posted $-0.32.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2017, last anual sales report draw a super good growth of 18.56% to $387.29 M dollars. In contrary, its profit margin (compared to sales) decreased to -12.70%, that is $-49.21 million.
|2013||$24 M||-||$-26.17 M-111.4%||-|
|2014||$33 M||38.61%||$-30.68 M-94.2%||17.23%|
|2015||$70 M||113.69%||$-67.43 M-96.9%||119.79%|
|2016||$229 M||228.28%||$-31.78 M-13.9%||-52.87%|
|2017||$327 M||42.96%||$-36.66 M-11.2%||15.36%|
|2018||$387 M||18.56%||$-49.21 M-12.7%||34.23%|
Quarterly financial resultsNevro posted $107.94 million in sales for 2018-Q4, a 12.88% up compared to previous quarter. Reported quarter earnings marked $-9.61 million with a profit margin of -8.90%. Profit margin inched a 2.88% compared to previous quarter when profit margin was -11.78%. When comparing revenues to same quarter last year, Nevro sales marked a brilliant increase and boosted a 10.19%.
|2017-Q1||$68 M||-||$-14.51 M-21.2%||-|
|2017-Q2||$78 M||14.00%||$-11.61 M-14.9%||-19.99%|
|2017-Q3||$82 M||5.43%||$-6.23 M-7.6%||-46.34%|
|2017-Q4||$98 M||19.10%||$-4.31 M-4.4%||-30.80%|
|2018-Q1||$88 M||-10.54%||$-17.71 M-20.2%||310.88%|
|2018-Q2||$96 M||9.64%||$-10.62 M-11.1%||-40.04%|
|2018-Q3||$96 M||-0.47%||$-11.27 M-11.8%||6.07%|
|2018-Q4||$108 M||12.88%||$-9.61 M-8.9%||-14.72%|
Nevro ownershipWhen you are planning to buy shares of a company, it's worth to have a look its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Nevro, 2.50% of all outstanding shares are owned by its staff.
Bearish positions for NVRO stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to Nevro:
|Market cap||$4.2 B|
|Total shares||31.0 M|
|Float shares||28.3 M|
|- Institutional holdings (%)||111.2%|
|- Insider holdings (%)||2.5%|
|Shares in short selling||0.0%|
|Thursday, February 27th, 2020|
|Day range||$133.64 - $140.25|
|Average true range||$5.01|
|50d mov avg||$127.01|
|100d mov avg||$111.82|
|200d mov avg||$91.53|
Nevro performanceTo better understand Nevro performance you must becnhmark its gains with other related stocks in same sector or industry. For Nevro, the benchmark is made against .